Scientific Retreat
MRA’s Annual Scientific Retreat is the premier annual convening of global thought leaders from across the melanoma research community. By bringing together physician scientists, pharmaceutical and biotech representatives, government officials, and patient advocates, this invitation-only, think-tank style conference aligns key stakeholders to present and discuss emerging ideas and issues shaping melanoma research from bench to bedside.
Previous Retreat Agendas and Reports
MRA 2021 Scientific Retreat
February 22 - February 24, 2021 - Virtual
The 2021 MRA Scientific Retreat will continue MRA’s history of featuring scientific excellence, facilitating interaction and early sharing of unpublished data through 12 lectures including 3 keynotes, panel discussions, networking roundtables and virtual poster presentations. The retreat is an invitation-only event and while typically capped at 300, we do anticipate raising that cap to 600 in 2021 to take advantage of the virtual platform.
The 2021 Scientific Retreat will take place February 22 – 24. The virtual format enables several exciting features including a rotating banner that can display corporate logos or other non-product specific messaging (subject to MRA approval), virtual exhibit booth with video conferencing allowing exhibitors to display branded materials and engage with attendees and the ability to schedule one-on-one meetings with retreat participants.
Participants will include leading scientists from the United States and abroad, as well as senior leadership from non-profit foundations, government agencies, industry, philanthropists and other like-minded organizations.
2021 Retreat Sponsorship Opportunities
Read the 2020 Retreat Report:
Melanoma > Exchange Advocate Forum
Dates TBD
Each year the Melanoma Research Alliance, the world's largest non-profit funder of melanoma research, hosts an exciting half-day Melanoma > Exchange Patient & Advocate Forum to bring together patients, loved ones, and researchers together to learn about cutting-edge advances in melanoma, the research pipeline, and the latest in melanoma prevention and early detection.
